杭州解百：董事陈建文离任

Group 1 - The core point of the article is the resignation of Chen Jianwen, a director of Hangzhou Jiebai, due to job relocation, and the company's revenue composition for the first half of 2025 [1] - Hangzhou Jiebai's revenue structure shows that 88.97% comes from the merchandise sales sector, while other businesses account for 11.03% [1] - As of the report, Hangzhou Jiebai has a market capitalization of 5.7 billion yuan [1] Group 2 - The article also mentions an investigation into the chairman of Peking University Pharmaceutical, Xu Xiren, prior to his arrest, indicating potential issues with asset disposal and unclear fund movements [1]